Drugs / red yeast rice
red yeast rice
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT07106996 | Jul 2025 → Jun 2026 overdue | polycystic ovary syndrome | Sichuan Provincial People's Hospital | Recruiting | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01687049 | Jan 2013 → Dec 2017 | prostate cancer | Dr. Laurence Klotz | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02726555 | Nov 2015 → May 2026 overdue | atherosclerosis, hyperlipidemia | Wenzhou Medical University | Recruiting | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT01490229 | Jan 2013 → Dec 2014 | coronary artery disorder | University of Roma La Sapienza | Unknown | No outcome recorded |
| Phase 4 | NCT01385020 | Jul 2011 | — | National Taiwan University Hospital | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00365742 | Apr → Jun 2006 | hyperlipidemia | Chestnut Hill Health System | Completed | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 4 | NCT01649986 Comparator | Jan 2014 → Dec 2015 | hyperlipidemia | University of Roma La Sapienza | Unknown | No outcome recorded |
| Phase 4 | NCT02001883 Comparator | Nov 2013 → Dec 2014 | coronary artery disorder | University of Roma La Sapienza | Unknown | No outcome recorded |
| — | NCT00405769 Comparator | Jan → Oct 2007 | coronary artery disorder, hyperlipidemia | Chestnut Hill Health System | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | red yeast rice | “nutraceutical combined pill (1 capsule/day containing red yeast rice 200 mg, policosanol 10 mg, and berberine 500 mg).” NCT02001883 ↗8“os, 1 pill containing red yeast rice 200 mg, policosanol 10 mg, and berberine 500 mg, once daily, 1 year” NCT01490229 ↗ “1 capsule/day containing red yeast rice 200 mg, policosanol 10 mg, and berberine 500 mg” NCT01649986 ↗ |
| Known as | LipoCol Forte | “Red yeast rice capsule (LipoCol Forte)is a nature product” NCT01385020 ↗ |
| Known as | RYR | “Red yeast rice (RYR), a fermented product that has both medicinal and edible properties, is one of the traditional Chinese medicines used in the treatment of metabolic diseases.” NCT07106996 ↗1“Red yeast rice (RYR), is a reddish-purple fermented rice, containing statins which are known to inhibit cholesterol synthesis.” NCT01687049 ↗ |
| Action | Inhibit | “inhibit cholesterol synthesis” NCT01687049 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Red yeast rice (RYR), a fermented product that has both medicinal and edible properties, is one of the traditional Chinese medicines used in the treatment of metabolic diseases.” NCT07106996 ↗ |
| Route | Oral | “600 mg red yeast rice capsule was administered orally with 240 mL water at 8 AM” NCT01385020 ↗ |